BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $37,210,000 | -65.7% | 990,943 | -63.9% | 1.00% | -65.0% |
| Q2 2018 | $108,429,000 | +52.2% | 2,743,647 | -6.3% | 2.84% | +42.5% |
| Q1 2018 | $71,224,000 | +911.0% | 2,927,449 | +1021.1% | 2.00% | +752.6% |
| Q4 2017 | $7,045,000 | -69.2% | 261,134 | -57.3% | 0.23% | -46.5% |
| Q3 2017 | $22,886,000 | +662.9% | 612,268 | +410.2% | 0.44% | +189.4% |
| Q2 2017 | $3,000,000 | – | 120,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |